Published on in Vol 6, No 12 (2022): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/37144, first published .
Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study

Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study

Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study

JMIR Formative Res: Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast #Cancerhttps://t.co/BkkcO4Faoc

2:07 PM · Dec 29, 2022

1
1

RT @jmirpub: JMIR Formative Res: Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast #Cancer With Pathog…

2:07 PM · Dec 29, 2022

1
1